Lonidamine cytotoxicity: Involvement of the lysosomal compartment

Journal of International Medical Research

Volumn 28, Issue 6, 2000, Pages 269-276

  Dell'Antone, P ^a   Bragadin, M ^b   Piergallini, L ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CA' FOSCARI UNIVERSITY OF VENICE   (Italy)

Author keywords

Acidic compartments; Crabtree effect; Ehrlich ascites tumour cells; Lonidamine; Proton permeability

Indexed keywords

ACRIDINE ORANGE; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; BAFILOMYCIN; FLUORESCENT DYE; GLUCOSE; GLUTAMINE; HEXOKINASE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; LONIDAMINE; NIGERICIN; OLIGOMYCIN; POTASSIUM ION; PROTON; PROTON PUMP; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE INHIBITOR; RNA;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LEVEL; CELL METABOLISM; CELL NUCLEUS; CELL PH; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; EHRLICH ASCITES TUMOR CELL; ENZYME INHIBITION; GLYCOLYSIS; ION CONDUCTANCE; LYSOSOME; MALE; MEMBRANE VESICLE; MOUSE; MOUSE STRAIN; NONHUMAN; PROTON TRANSPORT;

EID: 0034534119     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000002800603     Document Type: Article

References (27)

1. Lonidamine and related compounds
2. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells
3. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells
4. Action of the antitumor and spermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor cells
5. Lonidamine mediated respiratory changes in rat heart myocytes: A re-examination of the functional response of mitochondrial cytochrome c oxidase
6. In vitro/in vivo correlations
7. Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore
8. On the mechanism of action of lonidamine: A study on human erythrocytes membrane
9. Effect of lonidamine on the membrane electrical properties of Ehrlich ascites tumor cells
10. The cytoskeleton as a subcellular target of the antineoplastic drug lonidamine
11. Relationship of cellular energy parameter to cytotoxicity for AG-17, lonidamine and cyclocreatine in four human cell lines
12. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance study
13. Involvement of vacuolar H(+)-adenosine triphosphatase activity in multidrug resistance in HL60 cells
14. Defective acidification in human breast tumor cells and implications for chemotherapy
15. Characterization of acidic vesicles in multidrug-resistant and sensitive cancer cells by acridine orange staining and confocal microspectrofluorometry
16. Metabolic pathways in Ehrlich ascites tumor cells recovering from a low bioenergetic status
17. On the mechanism of the glucose-induced ATP catabolism in ascites tumour cells and its reversal by pyruvate
18. Metabolic regulation of the adenine nucleotide pool. Studies on the transient exhaustation of the adenine nucleotides by glucose in Ehrlich ascites tumor cells
19. Ca++-induced dissipation of intracellular proton gradient in rat thymocytes
20. Differential staining of DNA and RNA in intact cells and isolated nuclei with acridine orange
21. Mechanism of action of lonidamine in the 9L brain tumor model involves inhibition of lactate efflux and intracellular acidification
22. Enhancement of doxorubicin content by the antitumor drug lonidamine in resistant Ehrlich ascites tumor cells through modulation of energy metabolism
23. The antineoplastic drug lonidamine interferes with the acidification mechanism of cell organelles
24. The chronic administration of drugs that inhibit the regulation of intracellular pH: In vitro and antitumor effects
25. Cellular pH gradient in tumor versus normal tissue: Potential exploitation for the treatment of cancer
26. The gene encoding H+-vacuolar ATP-ase subunit c is overexpressed in multidrug resistant HL60 cells
27. Tamoxifen inhibits acidification in cells independent of estrogen receptor